Citius Oncology, Inc. Common Stock (NASDAQ: CTOR) last traded at $0.840, up 0.60% on the session. The quote above updates while this page is open; the figures below are drawn from Citius Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Citius Oncology, Inc. Common Stock trades on NASDAQ under the ticker CTOR. Its market capitalisation is $78.10 million.
Valuation measures for Citius Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $78.10M |
|---|---|
| Enterprise value | $133.25M |
| Price / book | 1.93 |
| Beta | 1.81 |
Trailing-twelve-month figures tagged in Citius Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$46.06M |
| EPS (TTM) | -$0.470 |
|---|
| Return on equity | -114.06% |
|---|
| Cash | $16.56M |
|---|
Range and volume for CTOR over the past 52 weeks.
| 52-week high | $2.25 |
|---|---|
| 52-week low | $0.491 |
| Volume | 71.0K |
| Average volume | 99.9K |
| Previous close | $0.835 |
Invest a chosen dollar amount in Citius Oncology, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CTOR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.